Senior Corporate Development Analyst
Amneal Pharmaceuticals
5 hours ago
Remote friendly (Bridgewater, NJ)
United States
Corporate Functions
Senior Corporate Development Analyst
Responsibilities:
- Independently build, refine, and maintain complex financial models to evaluate licensing deals, partnerships, and M&A opportunities (cash flow analysis, NPV/IRR, sensitivity analysis, scenario modeling).
- Conduct advanced market and competitive research (industry trends, pipeline activity, new drug approvals, ANDA dynamics) to identify and assess growth opportunities.
- Own deal pipeline analytics and reporting, including tracking opportunities, transaction assumptions, risks, and key milestones.
- Create executive-ready presentations translating complex financial and strategic analysis into actionable insights.
Additional Responsibilities:
- Design and maintain dashboards and visualizations using BI tools (e.g., Power BI, Tableau).
- Use SQL to extract, manipulate, and analyze large datasets.
- Collaborate cross-functionally with Commercial, Finance, Regulatory, Legal, and R&D to develop comprehensive business cases.
- Prepare materials for executive leadership and Board-level reviews (investment recommendations, valuation summaries, strategic narratives).
- Apply enterprise financial systems/tools (e.g., Oracle Hyperion EPM, SQL-based platforms) to analyze portfolio performance.
- Partner with Finance on forecasting and long-range planning.
- Identify opportunities to improve modeling rigor and reporting efficiency.
Required Qualifications:
- Experience supporting licensing, partnership, or M&A evaluations with increasing independence and judgment.
- Exposure to pharmaceutical/healthcare industry dynamics (generics, branded pharmaceuticals, biosimilars, FDA regulatory pathways).
- Advanced Excel proficiency; ability to build and audit financial models from scratch.
- Strong PowerPoint and storytelling skills.
- Working knowledge of SQL.
- Proven ability to manage multiple workstreams in a fast-paced, deadline-driven environment.
- Strong written and verbal communication; confident engaging senior leaders and cross-functional partners.
- Ownership mindset (proactive, curious, comfortable in ambiguity).
Education:
- Bachelor’s degree (BA/BS) required.
Preferred Qualifications:
- Master’s degree (MBA or MS).
Experience:
- 4–8 years in corporate development, FP&A, strategy, investment banking, consulting, or similar analytical role.
- 2+ years with valuation methodologies (DCF, comparable transactions, royalty-based structures, risk-adjusted valuation).
- 1+ year translating analysis into recommendations that influence strategic/investment decisions.
Compensation/Benefits (if applicable):
- Salary range: $80,000–$105,000 per year.
- Short-term incentive opportunity (bonus/performance-based award) within first 12 months.
- 401(k) matching and health/insurance benefits (as part of Total Rewards program).
Responsibilities:
- Independently build, refine, and maintain complex financial models to evaluate licensing deals, partnerships, and M&A opportunities (cash flow analysis, NPV/IRR, sensitivity analysis, scenario modeling).
- Conduct advanced market and competitive research (industry trends, pipeline activity, new drug approvals, ANDA dynamics) to identify and assess growth opportunities.
- Own deal pipeline analytics and reporting, including tracking opportunities, transaction assumptions, risks, and key milestones.
- Create executive-ready presentations translating complex financial and strategic analysis into actionable insights.
Additional Responsibilities:
- Design and maintain dashboards and visualizations using BI tools (e.g., Power BI, Tableau).
- Use SQL to extract, manipulate, and analyze large datasets.
- Collaborate cross-functionally with Commercial, Finance, Regulatory, Legal, and R&D to develop comprehensive business cases.
- Prepare materials for executive leadership and Board-level reviews (investment recommendations, valuation summaries, strategic narratives).
- Apply enterprise financial systems/tools (e.g., Oracle Hyperion EPM, SQL-based platforms) to analyze portfolio performance.
- Partner with Finance on forecasting and long-range planning.
- Identify opportunities to improve modeling rigor and reporting efficiency.
Required Qualifications:
- Experience supporting licensing, partnership, or M&A evaluations with increasing independence and judgment.
- Exposure to pharmaceutical/healthcare industry dynamics (generics, branded pharmaceuticals, biosimilars, FDA regulatory pathways).
- Advanced Excel proficiency; ability to build and audit financial models from scratch.
- Strong PowerPoint and storytelling skills.
- Working knowledge of SQL.
- Proven ability to manage multiple workstreams in a fast-paced, deadline-driven environment.
- Strong written and verbal communication; confident engaging senior leaders and cross-functional partners.
- Ownership mindset (proactive, curious, comfortable in ambiguity).
Education:
- Bachelor’s degree (BA/BS) required.
Preferred Qualifications:
- Master’s degree (MBA or MS).
Experience:
- 4–8 years in corporate development, FP&A, strategy, investment banking, consulting, or similar analytical role.
- 2+ years with valuation methodologies (DCF, comparable transactions, royalty-based structures, risk-adjusted valuation).
- 1+ year translating analysis into recommendations that influence strategic/investment decisions.
Compensation/Benefits (if applicable):
- Salary range: $80,000–$105,000 per year.
- Short-term incentive opportunity (bonus/performance-based award) within first 12 months.
- 401(k) matching and health/insurance benefits (as part of Total Rewards program).